Abstract
In recent years, genomic-based blood testing has been heralded as a promising tool for early detection in a wide range of cancers. At the American Association for Cancer Research Virtual Annual Meeting I, two research teams independently developing such blood tests reported compelling data on the specificity and sensitivity of their tests.
©2020 American Association for Cancer Research.
2020
American Association for Cancer Research.
You do not currently have access to this content.